Related Experiment Videos
[Epidemiology of measles and mumps. 1st part: measles (author's transl)]
Padiatrie Und Padologie
|January 1, 1979
Abstract:
Measles morbidity is seen to follow a cyclic pattern with peaks and ebbs every 2--3 years. The maximum in the annual course is found in the second quarter, the peak of the age-specific morbidity in Central Europe in the 4th year of life. At 15 years of age, seroconversion is practically 100%. Complications can be expected in 6,7% of cases, mortality in about 1:10,000. Encephalitis occurs in about 1,2% of cases and is often followed by neurological and psychical damage.
Insights
Measles infections occur cyclically every 2-3 years, peaking in spring. While most children develop immunity by age 15, complications like encephalitis can occur, impacting neurological health.
Area of Science:
- Epidemiology
- Pediatrics
- Immunology
Context:
- Measles exhibits a distinct cyclic pattern in morbidity, with peaks occurring every 2-3 years.
- Annual measles incidence peaks in the second quarter.
- Age-specific morbidity in Central Europe predominantly affects children in their 4th year of life.
Purpose:
- To describe the epidemiological patterns of measles, including its cyclical nature, seasonality, and age distribution.
- To outline the seroconversion rates and the incidence of complications and mortality associated with measles.
- To detail the occurrence and potential long-term consequences of measles-related encephalitis.
Summary:
- Measles morbidity follows a 2-3 year cyclic pattern, with peak incidence in the second quarter of the year.
- The highest age-specific morbidity is observed in 4-year-old children in Central Europe.
- Seroconversion approaches 100% by 15 years of age, but complications like encephalitis (1.2%) can lead to neurological damage, with an overall mortality rate of approximately 1:10,000.
Impact:
- Provides crucial data for public health strategies and vaccination campaigns targeting measles.
- Highlights the importance of monitoring measles incidence and vaccination coverage in pediatric populations.
- Informs healthcare providers about the risks of measles complications, particularly encephalitis and its sequelae.